Taiwan FDA registration 1d47a61bf06bc00c5da8f89aec5ab32c
"Cyrex" immune cell function analysis
TW: 〝賽雷克斯〞免疫細胞功能分析
Taiwan·Risk Class 2·CYLEX INC.·Registered Oct 01, 2008 – Oct 01, 2013CancelledRegistration details
- Analysis ID
- 1d47a61bf06bc00c5da8f89aec5ab32c
- Customs Code
- DHA00601945207
Company information
- Manufacturer
- CYLEX INC.
- Manufacturer Country
- United States
- Authorized Representative
- KINGDOM EAST ENTERPRISE CO., LTD.
Product details
- Intended Use
- Cerex immune cell function analysis is the analysis of ATP adenylate triphosphate in stimulated CD4 cells to detect CMI of the immune system through cells. This measurement is done using a sodium-phospholipid heparin anticoagulant in the blood, using a luciferase measuring machine and luciferin or luciferase. The assay is used to detect the suppressive immunity of the cellular immune system of CMI.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.5220 Automatic Differentiation Cell Counter
- Import Information
- import
Dates and status
- Registration Date
- Oct 01, 2008
- Expiry Date
- Oct 01, 2013
- Cancellation Date
- Jun 03, 2015
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Cyrex" immune cell function analysis in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1d47a61bf06bc00c5da8f89aec5ab32c and manufactured by CYLEX INC.. The authorized representative in Taiwan is KINGDOM EAST ENTERPRISE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices